Title : Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects - Neuvonen_2018_Basic.Clin.Pharmacol.Toxicol_122_341 |
Author(s) : Neuvonen M , Tarkiainen EK , Tornio A , Hirvensalo P , Tapaninen T , Paile-Hyvarinen M , Itkonen MK , Holmberg MT , Karja V , Mannisto VT , Neuvonen PJ , Pihlajamaki J , Backman JT , Niemi M |
Ref : Basic Clin Pharmacol Toxicol , 122 :341 , 2018 |
Abstract : |
PubMedSearch : Neuvonen_2018_Basic.Clin.Pharmacol.Toxicol_122_341 |
PubMedID: 28990360 |
Gene_locus related to this paper: human-CES1 |
Title : The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study - Todorova_2004_J.Clin.Endocrinol.Metab_89_2019 |
Author(s) : Todorova B , Kubaszek A , Pihlajamaki J , Lindstrom J , Eriksson J , Valle TT , Hamalainen H , Ilanne-Parikka P , Keinanen-Kiukaanniemi S , Tuomilehto J , Uusitupa M , Laakso M |
Ref : J Clinical Endocrinology Metab , 89 :2019 , 2004 |
Abstract : |
PubMedSearch : Todorova_2004_J.Clin.Endocrinol.Metab_89_2019 |
PubMedID: 15126514 |
Title : G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia - Pihlajamaki_2000_Arterioscler.Thromb.Vasc.Biol_20_1789 |
Author(s) : Pihlajamaki J , Karjalainen L , Karhapaa P , Vauhkonen I , Taskinen MR , Deeb SS , Laakso M |
Ref : Arterioscler Thromb Vasc Biol , 20 :1789 , 2000 |
Abstract : |
PubMedSearch : Pihlajamaki_2000_Arterioscler.Thromb.Vasc.Biol_20_1789 |
PubMedID: 10894818 |